Picolylamides of the nicethamide type. 6. Structure-activity relationships of analeptics of the nicethamide type
Sattler, H.J.; Schmitz, H.; Schunack, W.
Pharmaceutica Acta Helvetiae 50(10): 298-303
1975
ISSN/ISBN: 0031-6865 PMID: 684 Document Number: 85323
Document emailed within 1 workday
Related Documents
Sattler, H.J.; Schunack, W.; Rochelmeyer, H. 1974: Structure-activity relationship of analeptics of the nicethamide type. 1. Diethylamide of homologous and vinylogs of nicotinic acid and isonicotinic acid Arzneimittel-Forschung 24(5): 743-746Mager, H.; Barth, A. 1979: Problems involved in the specification and interpretation of quantitative structure-activity relationships. Part 1: a modified type of structure-activity equations Die Pharmazie 34(9): 557-559
Simpson, L.L.; Dasgupta, B.R. 1983: Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships Journal of Pharmacology and Experimental Therapeutics 224(1): 135-140
McKean, D.J.; Podzorski, R.P.; Bell, M.P.; Nilson, A.E.; Huntoon, C.J.; Slack, J.; Dower, S.K.; Sims, J. 1993: Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity Journal of Immunology 151(7): 3500-3510
Mast, T.Christopher.; Kierstead, L.; Gupta, S.B.; Nikas, A.A.; Kallas, E.G.; Novitsky, V.; Mbewe, B.; Pitisuttithum, P.; Schechter, M.; Vardas, E.; Wolfe, N.D.; Aste-Amezaga, M.; Casimiro, D.R.; Coplan, P.; Straus, W.L.; Shiver, J.W. 2010: International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials Vaccine 28(4): 950-957
Wang, E.H.; Du, F.D.; Xiang, B.R. 1981: Molecular connectivity studies on quantitative structure-activity of drugs. II. Quantitative structure-activity relationships for leucomycins, lincomycins and clindamycins Yao Xue Xue Bao 16(2): 86-91
Takeuchi, K.; Ito, K.; Namikawa, S. 1990: Anti-inflammatory activity of the dry distillation tar of delipidated soybean (Glyteer) (3). Effects on type I-type IV allergic reaction Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 95(4): 149-157
Jönsson, N.A. 1972: Chemical structure and teratogenic properties. 3. a review of available data on structure-activity relationships and mechanism of action of thalidomide analogues Acta Pharmaceutica Suecica 9(6): 521-542
Altomare, C.; Carotti, A.; Cellamare, S.; Carrieri, A.; Ciabatti, R.; Malabarba, A. 1994: Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships Journal of Pharmacy and Pharmacology 46(12): 994-999
Antonaci, S.; Jirillo, E.; Garofalo, A.R.; Polignano, A.; Resta, F.; Pugliese, P.; Capurso, A.; Bonomo, L. 1988: Cell-mediated immune response in patients with type IIa, type IIb and type IV primary hyperlipoproteinaemia Cytobios 54(218-219): 181-189
Stanković, S. 2001: X-rays in molecular biophysics: structure-activity relationships and activity of steroid hormones Medicinski Pregled 54(9-10): 413-421
Cechinel Filho, V.; Pinheiro, T.; Nunes, R.J.; Yunes, R.A.; Cruz, A.B.; Moretto, E. 1994: Antibacterial activity of N-phenylmaleimides, N-phenylsuccinimides and related compounds. Structure-activity relationships Farmaco 49(10): 675-677
Richards, R.K. 1980: Structure-activity relationships in the effects of phenacemide analogs on serum creatinine and anticonvulsant activity Archives Internationales de Pharmacodynamie et de Therapie 244(1): 107-112
Berntorp, E.; Jarevi, G.; Vedback, A.; Nilsson, I.M. 1986: Living adenovirus type 4 vaccine human t lymphotropic virus type iii antibodies in swedish hemophiliacs in relation to type and dosage of factor concentrate Thrombosis Research (Suppl 6): 18
Holland, S.K.; Harlos, K.; Blake, C.C. 1987: Deriving the generic structure of the fibronectin type II domain from the prothrombin Kringle 1 crystal structure EMBO Journal 6(7): 1875-1880
Szolcsányi, J.; Jancsó-Gábor, A. 1976: Sensory effects of capsaicin congeners. Part II: Importance of chemical structure and pungency in desensitizing activity of capsaicin-type compounds Arzneimittel-Forschung 26(1): 33-37
Rathore, A.; Chatterjee, A.; Sivarama, P.; Yamamoto, N.; Singhal, P.K.; Dhole, T.N. 2009: Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians Aids Research and Human Retroviruses 25(11): 1149-1156
Gombar, V. 1986: Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols Arzneimittel-Forschung 36(7): 1014-1018
Rosenkranz, H.S.; Frierson, M.R.; Klopman, G. 1986: Use of structure-activity relationships in predicting carcinogenesis Iarc Scientific Publications 1986(83): 497-517
Su, Z.Z.; Leon, J.A.; Jiang, H.; Austin, V.N.; Zimmer, S.G.; Fisher, P.B. 1993: Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells Cancer Research 53(8): 1929-1938